In line with this, Sema3C has been reported to promote survival and tumorigenicity of glioma stem cells in an autocrine/paracrine manner (74), and to enhance adhesion, migration and invasion of breast cancer cells (75, 76). Here, SEMA3C is linked to breast cancer.